Aimed Alliance’s Executive Director, Stacey Worthy, will moderate a panel discussion entitled “The Future of Value Based Pricing Initiatives” at the 2016 FDA/CMS Summit on December 14, 2016. Panelists will discuss the challenges, opportunities, and innovations around value-based initiatives and how they impact patients. For more info, read here: https://lifesciences.knect365.com/fda-cms/agenda/1.
Last Updated on May 12, 2020 by Aimed Alliance
